US-based Merck & Co has announced plans to buy Tilos Therapeutics, its latest acquisition in the immunotherapy space.
The US International Trade Commission has issued a judgment after a surgical appliances company, Polymer Technology Systems (PTS), filed a complaint against a China-based competitor.
Eli Lilly has asked the US Supreme Court to reconsider a lower court’s ruling which ordered the drugmaker to pay Germany-based Erfindergemeinschaft UroPep $20 million for patent infringement.
A group of more than 100 medical, scientific, patient advocacy and women’s health organisations have opposed a recent proposal to amend section 101 of the US Patent Act.
The EU’s General Court has upheld the European Union Intellectual Property Office’s finding that a trademark for dietary supplements was descriptive of the relevant services to an Italian speaking public.
San Francisco-based biotech company Atomwise could be set to receive up to $1 million per target in milestone payments following a partnership agreement with Eli Lilly.
A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.
Danish research company Bioneer has secured a non-exclusive licence to CRISPR/Cas9 technology owned by French geneticist Emmanuelle Charpentier.
A Japanese court has dismissed a patent infringement lawsuit brought by Roche subsidiary Genentech against Sandoz, a division of Novartis.
The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.